HOG
38
3
MMC
62
5
FLR
46
-2
M
52
-3
CMA
50
-2
RCL
70
-2
QRVO
33
2
LMT
59
5
UAL
58
-5
HBI
33
2
CI
62
12
AEE
46
3
HRL
39
3
V
72
4
HCP
78
2
PHM
71
-3
HPE
25
-2
AN
58
-3
SYY
56
2
NDAQ
49
-3
HOG
38
3
MMC
62
5
FLR
46
-2
M
52
-3
CMA
50
-2
RCL
70
-2
QRVO
33
2
LMT
59
5
UAL
58
-5
HBI
33
2
CI
62
12
AEE
46
3
HRL
39
3
V
72
4
HCP
78
2
PHM
71
-3
HPE
25
-2
AN
58
-3
SYY
56
2
NDAQ
49
-3
Financhill
Back

Viking Therapeutics Stock Predictions

NOW is the time to get in on this trillion-dollar megatrend

Get it here.
Buy
73

VKTX
Viking Therapeutics

Last Price:
77.76
Seasonality Move:
16.43%

7 Day Trial

ALL ACCESS PASS

$ 7

9,530x the last time this happened

Here's what our expert says you should buy before April 14.

Viking Therapeutics Stock Forecast

  • Over the next 52 weeks, Viking Therapeutics has on average historically risen by 169% based on the past 8 years of stock performance.
  • Viking Therapeutics has risen higher in 5 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 62.5%
  • Is Viking Therapeutics Stock Undervalued?
    The current Viking Therapeutics [VKTX] share price is $79.59. The Score for VKTX is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
  • VKTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.

Will Viking Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Viking Therapeutics has on average historically risen by 169% based on the past 8 years of stock performance.

Viking Therapeutics Stock Rating

Buy
73
Viking Therapeutics (VKTX) is a Buy

Is Viking Therapeutics overpriced?

  • Viking Therapeutics has risen higher in 5 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 62.5%

Viking Therapeutics Stock Price History

Is VKTX stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VKTX is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
vikingtherapeutics.com

52-Week Data

52-Week High:
99.41
52-Week Low:
8.28

Prediction Charts

Market Cap:
8.78B
Price in USD:
79.59
Volume:
3.54M
Beta:
1.50

Technical Analysis

SMA50:
73.94
SMA100:
48.95
SMA200:
30.88
52-Wk Change:
248.16%

Stock Predictions

  • Is Viking Therapeutics stock public?
    Yes, Viking Therapeutics is a publicly traded company.
  • What is the Viking Therapeutics stock quote today?
    The Viking Therapeutics stock price is 79.59 USD today.
  • How to buy Viking Therapeutics stock online?
    You can buy Viking Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-18 66.13 64.73 66.25 64.50
Apr-19 64.54 63.37 65.80 61.64
Apr-22 64.13 63.90 64.94 62.30
Apr-23 64.45 64.93 67.58 63.51
Apr-24 65.75 65.07 67.78 64.43
Apr-25 63.00 68.86 69.17 62.56
Apr-26 69.00 74.31 74.64 68.22
Apr-29 74.54 75.42 76.44 73.50
Apr-30 75.00 79.57 80.25 74.80
May-1 78.31 76.43 80.38 75.66
May-2 78.13 75.76 78.13 73.41
May-3 74.49 76.97 77.68 72.88
May-6 76.97 78.20 79.88 73.69
May-7 78.27 79.59 81.86 76.51

Viking Therapeutics Earnings

Viking Therapeutics Earnings Report: Per Share Viking Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Viking Therapeutics Forecast Revenue Growth

Viking Therapeutics Stock Analysis: Historical quarterly revenues per share for Viking Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.01 per share, a decrease this year of $0.16 per share, and a decrease next year of $0.41 per share.

* Viking Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.